Controlling Seizures in Pediatric Patients: Exploring the Profile of an Antiseizure Medication

Join Dr Michael Chez and Dr Ajay Gupta as they discuss treatment considerations for pediatric patients with epilepsy and review the relevant clinical profile of FYCOMPA® (perampanel) with respect to these patients.

View Transcript
Share

INDICATION
FYCOMPA® (perampanel) is indicated in patients with epilepsy aged 4 years and older for partial-onset seizures (POS) with or without secondarily generalized seizures and adjunctive therapy for patients aged 12 years and older for primary generalized tonic-clonic (PGTC) seizures.

Please see additional Important Safety Information throughout and full US Prescribing Information, including Boxed WARNING.

Faculty

Michael G. Chez, MD, FAAN, FAES
Pediatric Epileptologist
Regional Director, Pediatric Epilepsy Research
Sutter Health
Roseville and Sacramento, CA
Professor, California State University
Elk Grove, CA
Ajay Gupta, MD
Section Head, Pediatric Epilepsy
Cleveland Clinic
Professor, Cleveland Clinic
Lerner College of Medicine
Cleveland, OH